Westin, Jenny E.4; Lindgren, Hanna S.4; Gardi, Jonathan Eyal3; Nyengaard, Jens Randel6; Brundin, Patrik4; Mohapel, Paul4; Cenci, Angela M.4
1 Institute of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus University2 The Department of Pathology - ÅKH, Faculty of Health Sciences, Aarhus University, Aarhus University3 Stereological Research Laboratory, Faculty of Health Sciences, Aarhus University, Aarhus University4 Lund University5 Department of Clinical Medicine - Stereological Research Laboratory, Department of Clinical Medicine, Health, Aarhus University6 Department of Clinical Medicine - Stereological Research Laboratory, Department of Clinical Medicine, Health, Aarhus University
3,4-Dihydroxyphenyl-L-alanine (L-DOPA)-induced dyskinesia is associated with molecular and synaptic plasticity in the basal ganglia, but the occurrence of structural remodeling through cell genesis has not been explored. In this study, rats with 6-hydroxydopamine lesions received injections of the thymidine analog 5-bromo-2'-deoxyuridine (BrdU) concomitantly with L-DOPA for 2 weeks. A large number of BrdU-positive cells were found in the striatum and its output structures (globus pallidus, entopeduncular nucleus, and substantia nigra pars reticulata) in L-DOPA-treated rats that had developed dyskinesia. The vast majority (60-80%) of the newborn cells stained positively for endothelial markers. This endothelial proliferation was associated with an upregulation of immature endothelial markers (nestin) and a downregulation of endothelial barrier antigen on blood vessel walls. In addition, dyskinetic rats exhibited a significant increase in total blood vessel length and a visible extravasation of serum albumin in the two structures in which endothelial proliferation was most pronounced (substantia nigra pars reticulata and entopeduncular nucleus). The present study provides the first evidence of angiogenesis and blood-brain barrier dysfunction in an experimental model of L-DOPA-induced dyskinesia. These microvascular changes are likely to affect the kinetics of L-DOPA entry into the brain, favoring the occurrence of motor complications.
Journal of Neuroscience, 2006, Vol 26, p. 9448-9461